FDA approves expanded use of Sanofi's type 1 diabetes drug
- Posted on June 13, 2026
- By Bing News
- 0 Views
- 1 min read
FDA approves expanded use of Sanofi's type 1 diabetes drug
June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's type 1 diabetes injection in children aged 8 to 17 years who were recently diagnosed with stage 3 of the condition. The FDA had first approved the drug, Tzield, in 2022 to delay the progression of type 1 diabetes from stage 2 to 3 in patients aged 8 years and older. Its label was
